GAMBARAN PENGETAHUAN DAN EVALUASI CARA PENGGUNAAN INSULIN PEN PASIEN DIABETES MELLITUS DI RUMAH SAKIT BHAYANGKARA POLDA BENGKUL
DOI:
https://doi.org/10.30649/obj.v7i1.152Abstract
Treatment for diabetes with insulin is given using an insulin pen. Pen insulin can be used alone by
the patient without requiring trained personnel. The patient's incomprehension in carrying out therapy is
one of the causes of therapy failure, due to the lack of knowledge and understanding of the patient
about the drug, everything related to the use of drugs for treatment.
The purpose of the study was to determine the knowledge based on the characteristics of
respondents, evaluation of insulin use pen, injection area, storage area, side effects. The study was
conducted by distributing questionnaires as primary data and sampling using purposive sampling
method. Respondents were patients with diabetes mellitus who used insulin pen in poly disease in
Bhayangkara Hospital. Data processed descriptively displayed with tables and graphs.
The results of the study were respondents with good knowledge, namely undergraduate 10
respondents (15.87%), civil servants and other jobs (pensioners, irt, students) each of 9 respondents
(14.29%), women15 respondents (23.81%), age 18 - 65 years 19 respondents (30.61%). Fast action
insulin and combination of 17 respondents (26.98%), novorapid 15 respondents (23.81%), no oral
drugs 44 respondents (69.84%), frequency 2 times a day, novomix 14 respondents (22 , 22%), 10-15
units 13 respondents (20.63%), insulin use> 1 year 27 respondents (42.86%), did not cause symptoms
57 respondents (90.48%). The use of the abdominal and arm areas of 23 respondents (35.51%),
storing in the refrigerator 32 respondents (50.79%), did not cause side effects 58 respondents (92.07%)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Oceana Biomedicina Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.